Retatrutide is a new medication in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in investigations. By activating these receptors, Retatrutide reduces hunger pangs, {promotesenergy expenditure, and ultimately contributes to significant slimming. While studies are still under